Allen Mirzaei, DPM
Primary Podiatric Medicine · Seaford, DENPI 1164859336
Payments from drug & device makers
Across 65 payments — averaging $87.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Supreme Orthopedic Systems, LLC$1K
- Medical Device Business Services, Inc.$1K
- Smith+Nephew$232
- Medtronic$219
- Treace Medical Concepts, Inc.$175
- plus $912 from 18 others
What the payments were for
- Travel & lodging$2,41942%
- Food & beverage$2,07936%
- Education$1,20021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 4 | $1,510 |
| Supreme Orthopedic Systems, LLC | 8 | $1,395 |
| Medical Device Business Services, Inc. | 7 | $1,255 |
| Smith+Nephew | 11 | $232 |
| Medtronic | 2 | $219 |
| Treace Medical Concepts, Inc. | 4 | $175 |
| Organogenesis Inc. | 7 | $170 |
| Bard Peripheral Vascular, Inc. | 2 | $137 |
| AbbVie | 1 | $115 |
| Stryker | 2 | $90 |
| Osiris Therapeutics Inc. | 2 | $79 |
| Intuitive Surgical | 1 | $77 |
| Kerecis Limited | 1 | $44 |
| Integra Lifesciences Corporation | 2 | $38 |
| Johnson & Johnson | 2 | $32 |
| KCI USA, Inc. | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| Cook Medical LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
| Abbott | 1 | $12 |
| Bioventus LLC | 1 | $12 |
| Paragon 28, Inc. | 1 | $11 |
| Medela LLC | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MOTOBAND$1,026
- VENOVO$129
- INTELLIS ADAPTIVESTIM$125
- DALVANCE$115
How this compares
Too few primary podiatric medicine providers in Delawareto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 17 | $12,697 |
| Ketoconazole | 124 | $4,577 |
| Ammonium Lactate | 56 | $1,312 |
| Gabapentin | 45 | $1,024 |
| Ciclopirox | 12 | $737 |
| Mupirocin | 35 | $400 |
| Doxycycline Hyclate | 15 | $292 |
| Colchicine | 15 | $269 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 22 | $248 |
| Terbinafine Hcl | 14 | $242 |
| Ibuprofen | 17 | $117 |
| Methylprednisolone | 16 | $95 |
| Tramadol Hcl | 13 | $56 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Seaford
- Christopher HeiseySeaford$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.